J&J is looking to add a hormone-sensitive indication to its prostate cancer therapy, which was originally approved in 2023.

The global Phase 3 Cosmic study is an open-label, randomized, active-controlled study in patients aged 2 to <7 years.

A breakthrough assay is advancing how researchers observe gene expression in real time. Named QRIVTA (quantitative real-time ...

The ability to analyze gene expression at the single-cell level—known as single-cell RNA sequencing (scRNA-seq)—has ...

Discover new treatments like ART-123 advancing toward approval to prevent long-term nerve damage caused by ...

Sofia Coppola, Keira Knightley, Penelope Cruz and Kirsten Dunst sat front row for this momentous closing show.

Aging can affect body odor through skin cell changes and the release of a cellular compound, requiring antioxidant-rich foods ...

US researchers are developing an AI-powered microscope system that could make soil health testing faster, cheaper, and more ...

The human brain is comprised of two main types of cells, known as neurons and glia. The first are responsible for ...

The health secretary has been noticeably quiet about a major MAHA obsession: sleep.

Smaller, more efficient models, customized AI solutions, and open-weight systems are making it possible for businesses to ...

Hot flashes are a menopausal hallmark: Up to 80 percent of women have them. But numerous lesser-known symptoms are also ...